I did say 'towards' being cash positive in my defence. At this end of the mkt cap scale its often binary - a little partnership deal for a small to medium-sized pharma, but a massive boost to OSX could so easily appear. I have long said I consider many of my small bio-tech stocks holdings like this, call options in effect. One of my other small-cap bio-tech's, destined for a capital raise at year end, pulled a partnership out at fin year end that sets it up until 2028 arguably, but more likely forever unless management cock their other applications up.
OSX could so easily announce similar.
Ann: Collaboration With Healthcare Group To Develop New Products, page-14
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.2¢ |
Change
0.002(5.00%) |
Mkt cap ! $4.853M | |||
| Open | High | Low | Value | Volume |
| 3.8¢ | 4.5¢ | 3.8¢ | $80.72K | 1.996M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 322736 | 4.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.2¢ | 1121312 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| OSX (ASX) Chart |